HLA-DRB1 is highly polymorphic, and is the strongest genetic risk for MS, raising the question of whether the observed differential methylation could be attributable to genetic variation in probe sequences used on the Illumina array. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.